@article{Palterer_Vitiello_Cammelli_2017, title={First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome}, volume={69}, url={https://www.reumatismo.org/reuma/article/view/923}, DOI={10.4081/reumatismo.2017.923}, abstractNote={Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis. Anti-transcription intermediary factor 1 gamma (anti-TIF1γ) antibodies have been found in both young adults affected by juvenile dermatomyositis and in elderly patients with cancer-associated myositis. In this regard, we report herein the first case of anti-TIF1γ dermatomyositis secondary to a myelodysplastic syndrome.}, number={2}, journal={Reumatismo}, author={Palterer, B. and Vitiello, G. and Cammelli, D.}, year={2017}, month={Aug.}, pages={75–77} }